Onn A - Search Results

1

Pulmonary dysfunction as a major cause of inoperability among patients with non-small-cell lung cancer.

Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Keus L, Lin E, Morice RC. Baser S, et al. Among authors: onn a. Clin Lung Cancer. 2006 Mar;7(5):344-9. doi: 10.3816/CLC.2006.n.017. Clin Lung Cancer. 2006. PMID: 16640807

2

Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2-expressing normal lung.

Lazar V, Raynaud J, Magidi S, Bresson C, Martini JF, Galbraith S, Wunder F, Onn A, Batist G, Girard N, Lassen U, Pramesh CS, Al-Omari A, Ikeda S, Berchem G, Blay JY, Solomon B, Felip E, Tabernero J, Rubin E, Philip T, Porgador A, Berindan-Neagoe I, Schilsky RL, Kurzrock R. Lazar V, et al. Among authors: onn a. Ther Adv Med Oncol. 2022 Oct 28;14:17588359221133893. doi: 10.1177/17588359221133893. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36324736 Free PMC article.

3

New targets for the treatment of advanced non-small cell lung cancer.

Massarelli E, Onn A, Zinner R, Khuri FR, Kim ES, Herbst RS. Massarelli E, et al. Among authors: onn a. Cancer Chemother Biol Response Modif. 2002;20:717-61. Cancer Chemother Biol Response Modif. 2002. PMID: 12703232 Review. No abstract available.

4

Development of an orthotopic model to study the biology and therapy of primary human lung cancer in nude mice.

Onn A, Isobe T, Itasaka S, Wu W, O'Reilly MS, Ki Hong W, Fidler IJ, Herbst RS. Onn A, et al. Clin Cancer Res. 2003 Nov 15;9(15):5532-9. Clin Cancer Res. 2003. PMID: 14654533

5

Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.

Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS. Onn A, et al. Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):136-43. doi: 10.1158/1078-0432.ccr-0373-3. Clin Cancer Res. 2004. PMID: 14734462

6

Treatment of non-small-cell lung cancer: a perspective on the recent advances and the experience with gefitinib.

Onn A, Tsuboi M, Thatcher N. Onn A, et al. Br J Cancer. 2004 Aug;91 Suppl 2(Suppl 2):S11-7. doi: 10.1038/sj.bjc.6602062. Br J Cancer. 2004. PMID: 15340373 Free PMC article. Review.

7

Current management of advanced non-small cell lung cancer: targeted therapy.

Isobe T, Herbst RS, Onn A. Isobe T, et al. Among authors: onn a. Semin Oncol. 2005 Jun;32(3):315-28. doi: 10.1053/j.seminoncol.2005.02.016. Semin Oncol. 2005. PMID: 15988686 Review.

8

Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome.

Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM. Onn A, et al. Radiology. 2005 Oct;237(1):342-7. doi: 10.1148/radiol.2371041650. Radiology. 2005. PMID: 16183941

9

Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.

Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, Morice RC. Baser S, et al. Among authors: onn a. Chest. 2006 Dec;130(6):1784-90. doi: 10.1378/chest.130.6.1784. Chest. 2006. PMID: 17166997

10

Pulmonary manifestations in patients with cutaneous T-cell lymphomas.

Baser S, Onn A, Lin E, Morice RC, Duvic M. Baser S, et al. Among authors: onn a. Cancer. 2007 Apr 15;109(8):1550-5. doi: 10.1002/cncr.22567. Cancer. 2007. PMID: 17351938 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters